{"id":1053015,"title":"DSEN Abstract: Crizotinib and Incidence of Death: A Systematic Review and Network Meta-analysis of ALK Inhibitors for Non-small Cell Lung Cancer - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-26","captureTimestamp":"2026-04-26T03:11:00.739000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54496.html","snippet":"DSEN Abstract Crizotinib and Incidence of Death: A Systematic Review and Network Meta-analysis of ALK Inhibitors for Non-small Cell Lung Cancer Summary We observed that all ALK inhibitors improved progression-free survival relative to chemotherapy, and that alectinib and…","rawSnapshotUrl":"/api/snapshots/raw/1053015","browseUrl":"https://replay.healtharchive.ca/job-8/20260426031100/https://cihr-irsc.gc.ca/e/54496.html#ha_snapshot=1053015","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}